EXPLAINED: Marker | Rare Historical Photos

Marker Therapeutics Stock Drops After Report About Lymphoma Treatment

Marker Therapeutics, Inc. (NASDAQ:MRKR) on Tuesday provided an update on the progress and clinical observations from the Phase 1 APOLLO study investigating MT-601, a Multi-Antigen Recognizing (MAR)-T cell product, in patients with lymphoma who have relapsed after anti-CD19 CAR-T cell therapy or for whom anti-CD19 CAR-T cell therapy is not…

Benzinga · Aug 26, 2025

Mexican Attorney General Will Demand Israel Turn Over Evidence Related To $25 Million Bribe In Spyware Deal

Mexican Attorney General Alejandro Gertz Manero said the country will demand Israel hand over evidence related to accusations that former president Enrique Peña Nieto took $25 million for facilitating deals involving surveillance technology

Latin Times · Jul 8, 2025

Former Mexican President Peña Nieto Accused of Taking $25 Million in Spyware Deal

Former Mexican President Enrique Peña Nieto allegedly received up to $25 million from two Israeli businessmen in exchange for facilitating deals involving surveillance technology

Latin Times · Jul 7, 2025

Disinfo black ops: exposing the companies and states spreading false information

‘Story killers’ project brings together 30 news outlets to shine a light on industrial disinformation campaigns

The Guardian - US · Feb 15, 2023

The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Apr 26, 2022

Three of Ireland's most expensive hotels given thousands in swimming pool grants

A TD said it was 'absolutely infuriating' the hotels got the funding when public pools have been shut down

Dublin Live · Apr 5, 2022

Why Are Marker Therapeutics Shares Trading Lower On Thursday?

Marker Therapeutics Inc (NASDAQ: MRKR) shares are trading lower after Roth Capital downgrades the company from Buy t

Benzinga · Feb 17, 2022

The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jan 20, 2022

Marker Therapeutics Stock Gains On FDA Orphan Drug Tag For Second MultiTAA-Cell Therapy For Pancreatic Cancer

The 

Benzinga · Jan 20, 2022